ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
+0.150 (3.39%)
Feb 13, 2026, 4:08 PM HKT

HKG:1541 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-302.68-315.86-379.46-402.89-732.95
Depreciation & Amortization
17.1120.6822.5817.6213.18
Loss (Gain) From Sale of Assets
-----0.56
Asset Writedown & Restructuring Costs
27.427.4---
Loss (Gain) From Sale of Investments
-14.15-14.15-1.76--1.6
Stock-Based Compensation
34.2134.2171.64103.8334.02
Other Operating Activities
-23.15-5.45-5.2420.69521.45
Change in Accounts Receivable
0.020.020.03-0.030.01
Change in Accounts Payable
27.5727.576.364.887.65
Change in Unearned Revenue
32.932.9---
Change in Other Net Operating Assets
64.6464.64-81.7117.21-31.74
Operating Cash Flow
-136.14-128.04-367.55-238.71-190.54
Capital Expenditures
-4.75-10.4-2.69-23.22-40.7
Sale of Property, Plant & Equipment
66.18---0.58
Investment in Securities
-24.9640.72-303.37-23.65
Other Investing Activities
6.427.6311.2123.27-92.25
Investing Cash Flow
42.8837.95-294.850.05-108.72
Short-Term Debt Issued
----0.01
Long-Term Debt Issued
-175.7879.96--
Total Debt Issued
186.78175.7879.96-0.01
Short-Term Debt Repaid
-----0.01
Long-Term Debt Repaid
--125.8-26.21-5.8-4.77
Total Debt Repaid
-141.23-125.8-26.21-5.8-4.78
Net Debt Issued (Repaid)
45.5549.9853.76-5.8-4.77
Issuance of Common Stock
215.94215.94307.79189.57800.98
Other Financing Activities
-8.01-6.99-30.51-4.39-3.17
Financing Cash Flow
253.48258.93331.04179.38793.03
Foreign Exchange Rate Adjustments
-1.671.793.1426.17-9.12
Miscellaneous Cash Flow Adjustments
-0.01-0.01---
Net Cash Flow
158.55170.62-328.23-33.11484.65
Free Cash Flow
-140.89-138.44-370.25-261.93-231.24
Free Cash Flow Margin
-114.70%-174.06%-4811.50%-4603.41%-1674.69%
Free Cash Flow Per Share
-0.36-0.37-1.02-0.79-2.68
Cash Interest Paid
4.473.451.520.790.89
Levered Free Cash Flow
-74.08-132.07-193.42-2,538-
Unlevered Free Cash Flow
-71.28-129.92-192.47-2,537-
Change in Working Capital
125.13125.13-75.3222.05-24.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.